StonvexLoading…
StonvexStonvexStonvexCore line items from KOSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $12.62M | $12.27M | $13.10M | $17.71M |
Operating Income | $-1.74M | $-1.87M | $-24.88M | $902.02K |
Net Income | $-874.83K | $-950.91K | $8.32M | $1.27M |
EPS (Diluted) | $-0.09 | $-0.10 | $0.85 | $0.13 |
Total Assets | $37.18M | $37.20M | $39.09M | $29.96M |
Total Liabilities | $6.57M | $6.05M | $7.28M | $7.26M |
Cash & Equivalents | $2.81M | $2.84M | $3.09M | $9.21M |
Free Cash Flow OCF − CapEx | $-705.63K | $-652.29K | $10.64M | $-1.05M |
Shares Outstanding | 9.46M | 9.30M | 9.23M | 9.15M |